Independence Blue Cross | Pipeline Drugs, Medicare Updates, BES: Behavioral Health Strategy
ALL SEGMENTS | RX
Pipeline drugs to watch — Q1 2023
Our Q1 2023 Rx Pipeline insights report highlights three drugs worth watching. They are expected to receive FDA approval within the next 12 months and may be eligible for coverage through the prescription drug or medical benefit. FULL ARTICLE
MEDICARE
Medicare business updates for March
This month, you will find information about the PowerPartner contest, system changes, Part B relatable drugs, and recording requirements. FULL ARTICLE
ALL SEGMENTS
Recorded viewing of the Broker Experience Series
Please join us on March 21, 2023, from 10 – 11 a.m. to view a recording of our most recent Broker Experience Series webcast, which focuses on our behavioral health strategy. Register today!
